Targeting p53 in chronic lymphocytic leukemiaRiccardo Moia, Gianluca Gaïdano, Paola Boggione et al.|Expert Opinion on Therapeutic Targets|2020Cited by 26
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Riccardo Moia, Wael Al Essa et al.|British Journal of Haematology|2022Cited by 24
Inducible T‐cell co‐stimulator (ICOS) and ICOS ligand are novel players in the multiple‐myeloma microenvironmentElena Boggio, Umberto Dianzani, Casimiro Luca Gigliotti et al.|British Journal of Haematology|2021Cited by 15
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic LeukemiaFortunato Morabito, Antonino Neri, Giovanni Tripepi et al.|Frontiers in Oncology|2021Cited by 12
Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE PlatformFabio Efficace, Marco Vignetti, Andrea Patriarca et al.|Frontiers in Oncology|2022Cited by 12